FDA approves eye drug Vabysmo to treat ‘wet’ macular degeneration in older adults … Diet rich in flavonoid-rich foods boosts longevity in Parkinson’s disease … Allopurinol not linked to higher...
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
Avastin more likely to cause blindness than Lucentis, study reports
By
McKnight's Staff
Jun 19, 2012
The cheaper of the two rival macular degeneration treatments could lead to blindness or other adverse events, new research determined.
Study: Daily aspirin increases the risk for macular degeneration in seniors
Jan 09, 2012
Daily doses of aspirin in elderly adults can double the risk for developing the “wet” version of age-related macular degeneration (AMD), according to a new study.